• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Influenza Other Respir Viruses . The impact of the SARS-CoV-2 pandemic on global influenza surveillance: Insights from 18 National Influenza Centers

tetano

Editor, Senior Moderator
Influenza Other Respir Viruses


. 2023 May 11;17(5):e13140.
doi: 10.1111/irv.13140. eCollection 2023 May. The impact of the SARS-CoV-2 pandemic on global influenza surveillance: Insights from 18 National Influenza Centers based on a survey conducted between November 2021 and March 2022

Lisa Staadegaard[SUP] 1 [/SUP], Marco Del Riccio[SUP] 1 2 [/SUP], Sytske Wiegersma[SUP] 1 [/SUP], Clotilde El Guerche-Séblain[SUP] 3 [/SUP], Erica Dueger[SUP] 3 [/SUP], Meral Akçay[SUP] 3 [/SUP], Jean-Sebastien Casalegno[SUP] 1 4 [/SUP], Michel Dückers[SUP] 1 5 6 [/SUP], Saverio Caini[SUP] 1 [/SUP], John Paget[SUP] 1 [/SUP]; NIC Collaborators



Collaborators, Affiliations
Free PMC article Abstract

Background: National Influenza Centers (NICs) have played a crucial role in the surveillance of SARS-CoV-2. The FluCov project, covering 22 countries, was initiated to monitor the impact of the SARS-CoV-2 pandemic on influenza activity.
Methods: This project consisted of an epidemiological bulletin and NIC survey. The survey, designed to assess the impact of the pandemic on the influenza surveillance system, was shared with 36 NICs located across 22 countries. NICs were invited to reply between November 2021 and March 2022.
Results: We received 18 responses from NICs in 14 countries. Most NICs (76%) indicated that the number of samples tested for influenza decreased. Yet, many NICs (60%) were able to increase their laboratory testing capacity and the "robustness" (e.g., number of sentinel sites) (59%) of their surveillance systems. In addition, sample sources (e.g., hospital or outpatient setting) shifted. All NICs reported a higher burden of work following the onset of the pandemic, with some NICs hiring additional staff or partial outsourcing to other institutes or departments. Many NICs anticipate the future integration of SARS-CoV-2 surveillance into the existing respiratory surveillance system.
Discussion: The survey shows the profound impact of SARS-CoV-2 on national influenza surveillance in the first 27 months of the pandemic. Surveillance activities were temporarily disrupted, whilst priority was given to SARS-CoV-2. However, most NICs have shown rapid adaptive capacity underlining the importance of strong national influenza surveillance systems. These developments have the potential to benefit global respiratory surveillance in the years to come; however, questions about sustainability remain.

Keywords: SARS‐CoV‐2; epidemics; influenza; public health; surveillance.

 
Back
Top Bottom